Dennis Williams, Pharm.D.
About Dennis Williams, Pharm.D.
Dennis Williams, Pharm.D., is the Senior Vice President of Late Stage Development at Adaptimmune, with a 20-year career in the pharmaceutical and biotech industries.
Current Position at Adaptimmune
Dennis Williams, Pharm.D., serves as the Senior Vice President of Late Stage Development at Adaptimmune. He has held this position since joining the company in 2015. In his role, he oversees the advanced stages of the company's development programs. Williams' leadership is central to navigating the final phases of product development, ensuring that therapeutic candidates are efficiently brought to the market.
Previous Roles in Regulatory Affairs
Dennis Williams has held significant roles in regulatory affairs, including serving as the Vice President of Global Regulatory Affairs at Adaptimmune. His expertise in regulatory strategies and compliance has been crucial to the company's efforts in developing and commercializing new therapies. His experience in this field spans various high-stakes regulatory processes and approvals.
Leadership in Development Programs
Dennis Williams has led key development programs at Adaptimmune, including the ADP-A2M4 program. He also spearheaded the NY-ESO development program, which eventually transitioned to GSK. His strategic oversight and industry experience have been instrumental in guiding these programs through complex development stages.
Experience in Pharmaceutical and Biotech Industries
With a career extending over 20 years, Dennis Williams has extensive experience in the pharmaceutical and biotech industries. He began his career at Teva Pharmaceuticals in 2000 and has since contributed to significant advancements and approvals, including the development and approval of PROMACTA/REVOLADE at GSK Oncology.
Educational Background
Dennis Williams holds a Doctorate in Pharmacy (Pharm.D.) from the University of Florida. He also earned a Bachelor of Science degree in Pharmacy from Temple University. His educational foundation has equipped him with the specialized knowledge required to excel in the pharmaceutical and biotech sectors.